Nalaganje...
Immune-related tumor response dynamics in melanoma patients treated with pembrolizumab: Identifying markers for clinical outcome and treatment decisions
PURPOSE: Characterize tumor burden dynamics during PD-1 inhibitor therapy and investigate the association with overall survival (OS) in advanced melanoma. EXPERIMENTAL DESIGN: The study included 107 advanced melanoma patients treated with pembrolizumab. Tumor burden dynamics were assessed on serial...
Shranjeno v:
| izdano v: | Clin Cancer Res |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5559305/ https://ncbi.nlm.nih.gov/pubmed/28592629 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-17-0114 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|